Chinese Medical Sciences Journal ›› 2016, Vol. 31 ›› Issue (2): 134-136.doi: 10.1016/S1001-9294(16)30039-6
• Case Reports • Previous Articles
Jian-bo Xu, Gang Xu, Guo-feng Chen, Dian-hua Gu, Jian-huai Zhang, Fu-zhen Qi*
Received:
2015-09-12
Published:
2016-06-20
Online:
2016-06-20
Jian-bo Xu, Gang Xu, Guo-feng Chen, Dian-hua Gu, Jian-huai Zhang, Fu-zhen Qi*. Hepatocellular Carcinoma with Hypersplenic Thrombocytopenia and Situs Inversus Totalis: A Case Report[J].Chinese Medical Sciences Journal, 2016, 31(2): 134-136.
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
1. | Murakami S, Terakado M, Misumi M, et al. Situs inversus totalis with malignant lymphoma of the stomach: report of a case. Surg Today 2003; 33:533-6. |
2. | Varano NR, Merklin RJ. Situs inversus: review of the literature, report of four cases and analysis of the clinical implications. J Int Coll Surg 1960; 33:131-48. |
3. | Yaghan RJ, Gharaibeh KI, Hammori S. Feasibility of laparoscopic cholecystectomy in situs inversus. J Laparo- endosc Adv Surg Tech A 2001; 11:233-7. |
4. | Douard R, Feldman A, Bargy F, et al. Anomalies of lateralization in man: a case of total situs inversus. Surg Radiol Anat 2000; 22:293-7. |
5. | Fulcher AS, Turner MA. Abdominal manifestations of situs anomalies in adults. Radiographics 2002; 22:1439-56. |
6. | Adler HL, Lerner SP. Renal cell carcinoma and situs inversus viscerum. J Urol 1998; 160:2141-2. |
7. | Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 2012; 380:1840-50. |
8. | Xu JB, Qi FZ, Xu G, et al. Value of alpha-fetoprotein and clinical characteristics in patients with liver neoplasm. Neoplasma 2014; 61:218-24. |
9. | Akahoshi T, Tomikawa M, Kawanaka H, et al. Laparos- copic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. J Gastroenterol Hepatol 2012; 27:286-90. |
10 | Hanazaki K, Kajikawa S, Adachi W, et al. Portal vein thrombosis may be a fatal complication after synch- ronous splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 2000; 191:341-2. |
11 | Wang C, Li C, Wen TF, et al. Safety of synchronous hepatectomy and splenectomy for patients with hepato- cellular carcinoma and hypersplenism. Hepatogastroen- terology 2012; 59:526-8. |
12 | Kim SH, Kim dY, Lim JH, et al. Role of splenectomy in patients with hepatocellular carcinoma and hypersp- lenism. ANZ J Surg 2013; 83:865-70. |
13 | Wu CC, Cheng SB, Ho WM, et al. Appraisal of concomitant splenectomy in liver resection for hepatocellular carcin- oma in cirrhotic patients with hypersplenic thrombocy- topenia. Surgery 2004; 136:660-8. |
14 | Horino K, Beppu T, Kuroki H, et al. Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma. Int J Clin Oncol 2013; 18: 829-38. |
15 | Nakagawa K, Tanaka K, Nojiri K, et al. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol 2014; 21:1711-8. |
16 | Kanematsu T, Matsumata T, Kohno H, et al. Hepato- cellular carcinoma with situs inversus. Cancer 1983; 51:549-52. |
17 | Niki Y, Shiraki K, Enokimura N, et al. Hepatocellular carcinoma associated with situs inversus totalis. J Clin Gastroenterol 2004; 38:382. |
18 | Kakinuma D, Tajiri T, Yoshida H, et al. A case of hepatocellular carcinoma with situs inversus totalis. J Nippon Med Sch 2004; 71:209-12. |
19 | Li T, Wang L, Chen RX, et al. Hepatocellular carcinoma with situs inversus totalis and polysplenia syndrome. Liver Int 2007; 27:1430-1. |
20 | Patel RB, Gupta NR, Vasava NC, et al. Situs inversus totalis (SIT) with hepatocellular carcinoma (HCC): a rare case report and review of 12 other cases. Indian J Surg 2013; 75:424-9. |
[1] | Wanshui Yang, Hanyu Jiang, Chao Liu, Jingwei Wei, Yu Zhou, Pengyun Gong, Bin Song, Jie Tian. Multi-Omics and Its Clinical Application in Hepatocellular Carcinoma: Current Progress and Future Opportunities [J]. Chinese Medical Sciences Journal, 2021, 36(3): 173-186. |
[2] | Qiong Chen,Xuefeng Yang. Research Progress in Targeted Therapy of Hepatocellular Carcinoma [J]. Chinese Medical Sciences Journal, 2021, 36(1): 57-65. |
[3] | Xu Yanhong,Yang Jia,Meng Jie,Wang Han. Targeted MR Imaging Adopting T1-Weighted Ultra-Small Iron Oxide Nanoparticles for Early Hepatocellular Carcinoma: An in vitro and in vivo Study [J]. Chinese Medical Sciences Journal, 2020, 35(2): 142-150. |
[4] | Zhang Xiufen, Yu Bo, Zhang Fuzheng, Guo Zijian, Li Lihua. microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro△ [J]. Chinese Medical Sciences Journal, 2017, 32(1): 34-43. |
[5] | Sheng-ning Zhang*, Li Li, Jiang-hua Ran, Jing Liu, Yu Liang, Yang Gao, Min-jie Yang. Laparoscopic Cholecystectomy in Situs Inversus Totalis: a Case Report [J]. Chinese Medical Sciences Journal, 2013, 28(4): 245-247. |
[6] | Ye Jin, Li Zhou, Ke-min Jin, and Bao-cai Xing. Expression of Plasminogen Activator Inhibitor-2 is Negatively Associated with Invasive Potential in Hepatocellular Carcinoma Cells△ [J]. Chinese Medical Sciences Journal, 2013, 28(1): 16-19. |
[7] | Yao Zhang, Hua Zhang, Au Elizabeth, Xiao-qing Liu. Epidemiology of Hepatitis B and Associated Liver Diseases in China [J]. Chinese Medical Sciences Journal, 2012, 27(4): 243-248. |
[8] | Ting-ting He, and Jia-he Tian*. Application of Positron Emission Tomography Molecular Probes in Hepatocellular Carcinoma Biological Imaging [J]. Chinese Medical Sciences Journal, 2011, 26(2): 113-118. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|
Supervised by National Health Commission of the People's Republic of China
9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China
Tel: 86-10-65105897 Fax:86-10-65133074
E-mail: cmsj@cams.cn www.cmsj.cams.cn
Copyright © 2018 Chinese Academy of Medical Sciences
All right reserved.
京公安备110402430088 京ICP备06002729号-1